Optimi Health Signs Psilocybin Supply Agreement With New Zealand-Based Mātai Medical Research Institute Optimi signs international natural psilocybin supply agreement with New Zealand-Based Mātai Medical Research Institute, on behalf of the Tū Wairua Project.

Drug Testing Market Size to Cross USD 15.7 Bn by 2033 with CAGR of 5.3% | Transparency Market Research Wilmington, Delaware, United States, March 20, 2023 (GLOBE NEWSWIRE) -- According to the latest research by Transparency Market Research, the drug testing market was estimated to attain a global...

Don't Use Drugs and Ride: Hospitals Treat Thousands of Drug-Related Bike Injuries Each Year PISCATAWAY, N.J., Sept. 26, 2022 (GLOBE NEWSWIRE) -- From 2019 to 2020, more than 11,000 people who had been using drugs were treated in U.S. emergency departments for injuries that occurred while...

Global Psychedelic Drugs Market Analysis Report 2022 Featuring AstraZeneca, COMPASS, Klarisana, F. Hoffmann-La Roche, Takeda Pharma, Dr. Reddy's Laboratories, Pfizer, Merck & Co., & Lundbeck Dublin, May 06, 2022 (GLOBE NEWSWIRE) -- The "Global Psychedelic Drugs Market Size & Share to 2027" report has been added to ResearchAndMarkets.com's offering. Increase in prevalence of...

"Substance Use, Pregnancy, and Baby" Symposium Draws on Expertise of Medical, Social Science Professionals Phoenix, AZ, Feb. 07, 2022 (GLOBE NEWSWIRE) -- This one-day symposium draws on the expertise of professionals from multiple medical and social science fields to address drug/medication-related...